HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

$HTGM HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based products and services, today announced a non‑exclusive license and supply agreement (“Agreement”) that will enable Firalis to commercialize a next‑generation sequencing (NGS)‑based theranostic product and services to predict rheumatoid arthritis (RA) patients response to anti‑TNFα therapy, and other research products and services for mRNA profiling of inflammatory‑autoimmune disorders. The Agreement is a next step in the parties’ relationship following the successful adaptation of Firalis’ BIOPRED* research‑use assay to HTG EdgeSeq technology.https://finance.yahoo.com/news/htg-molecul...

Read more

Recommended & Related Posts

Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT

$HTGM Q1 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT

$HTGM Q1 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT

$HTGM Q1 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT

$HTGM Q1 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT

$HTGM Q1 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more

There are more for you ...

View more and participate in our discussion now. It's FREE.

Creating an account means you’re okay with InvestingNote's Terms and Conditions